(S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline | 781662-35-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline
• 英文别名: 3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-3,4-dihydro-1H-isoquinoline；(3S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline
• CAS: 781662-35-9
• 化学式: C₁₉H₁₉N₃
• 分子量: 289.38
• InChiKey: NSCFGLLIJSOVGL-KRWDZBQOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  40.7
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline 在 1-羟基苯并三唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三氟乙酸 作用下， 生成 (S)-2-Amino-3-(4-hydroxy-2,6-dimethyl-phenyl)-1-[(S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-3,4-dihydro-1H-isoquinolin-2-yl]-propan-1-one
  参考文献：
  名称：

  Identification of potent phenyl imidazoles as opioid receptor agonists

  摘要：

  Using previously reported opioid receptor (OR) agonist analogs 4a-c as starting points, the structure-activity relationship (SAR) for their related series has been further refined. This SAR Study has led to the identification of 2,6-di-Me-Tyr (DMT) analogs 4h and 4j as the most potent OR agonist within the series. in addition, it was discovered that 4-(aminocarbonyl)-2,6-dimethyl-Phe is a reasonable bioisostere surrogate for the DMT moiety, as supported by the OR activities Of Compounds 4x and 4y. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.01.082
• 作为产物：
  描述：

  (S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester 在 三氟乙酸 作用下， 反应 0.5h， 生成 (S)-3-(5-methyl-4-phenyl-1H-imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  Novel compounds as opioid receptor modulators

  摘要：

  这项发明针对的是作为阿片受体调节剂、拮抗剂和激动剂的新型化合物，它们可用于治疗由阿片类药物调节的疾病，如疼痛和胃肠疾病。

  公开号：

  US20040010014A1

文献信息

• Novel compounds as opioid receptor modulators
  申请人：——

  公开号：US20040010014A1

  公开（公告）日：2004-01-15

  This invention is directed towards novel compounds as opioid receptor modulators, antagonists, and agonists useful for the treatment of opioid modulated disorders such as pain and gastrointestinal disorders.

  这项发明针对的是作为阿片受体调节剂、拮抗剂和激动剂的新型化合物，它们可用于治疗由阿片类药物调节的疾病，如疼痛和胃肠疾病。
• TRIPEPTIDYL PEPTIDASE INHIBITORS
  申请人：Breslin Joseph Henry

  公开号：US20080108653A1

  公开（公告）日：2008-05-08

  The present invention is concerned with novel compounds of formula (I) which are inhibitors of a membrane tripeptidyl peptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinis (CCKs). The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds. wherein n is an integer 0 or 1; X represents O; S; or —(CR 4 R 5 ) m — wherein m is an integer 1 or 2; R 4 and R 5 are each independently from each other hydrogen or C 1-4 alkyl; R 1 is C 1-6 alkylcarbonyl optionally substituted with hydroxy; C 1-6 alkyloxycarbonyl; aminoC 1-6 alkylcarbonyl wherein the C 1-6 alkyl group is optionally substituted with C 3-6 cycloalkyl; mono- and di(C 1-4 alkyl)aminoC 1-6 alkylcarbonyl; aminocarbonyl substituted with aryl; C 1-6 alkylcarbonyloxyC 1-6 alkylcarbonyl; C 1-6 alkyloxycarbonylaminoC 1-6 alkylcarbonyl wherein the amino group is optionally substituted with C 1-4 alkyl; an amino acid; C 1-6 alkyl substituted with amino; or arylcarbonyl; R 2 is an optionally substituted 5-membered heterocycle, or R 2 is optionally substituted benzimidazole; R 3 is a bivalent radical —CH 2 CH 2 — optionally substituted with halo or phenylmethyl; or R 3 is a bivalent radical of formula

  本发明涉及公式（I）的新化合物，该化合物是膜三肽基肽酶的抑制剂，该酶负责失活内源性神经肽，如胆囊收缩素（CCK）。本发明还涉及制备此类化合物的方法，包括含有该化合物的制药组合物以及该化合物作为药物的用途。 其中，n是整数0或1；X代表O、S或-（CR4R5）m-，其中m是整数1或2；R4和R5各自独立于氢或C1-4烷基；R1是C1-6烷基羰基，可选地取代羟基；C1-6烷氧羰基；氨基C1-6烷基羰基，其中C1-6烷基基团可选地取代C3-6环烷基；单和双（C1-4烷基）氨基C1-6烷基羰基；取代芳基的氨基羰基；C1-6烷基羰氧基C1-6烷基羰基；C1-6烷氧羰基氨基C1-6烷基羰基，其中氨基可选地取代C1-4烷基；氨基酸；取代氨基的C1-6烷基；或芳基羰基；R2是可选取代的5-成员杂环，或R2是可选取代的苯并咪唑；R3是二价基团-CH2CH2-，可选地取代卤素或苯甲基；或R3是公式的二价基团
• Heterocyclic derivatives as opioid receptor modulators
  申请人：Janssen Pharmaceutica NV

  公开号：EP2275105A1

  公开（公告）日：2011-01-19

  This invention is directed towards compounds of formula (II) as intermediates for opioid receptor modulators, antagonists, and agonists useful for the treatment of opioid modulated disorders such as pain and gastrointestinal disorders.

  本发明的目的是将式（II）化合物作为阿片受体调节剂、拮抗剂和激动剂的中间体，用于治疗阿片受体调节紊乱，如疼痛和胃肠功能紊乱。
• US7202381B2
  申请人：——

  公开号：US7202381B2

  公开（公告）日：2007-04-10
• US7659402B2
  申请人：——

  公开号：US7659402B2

  公开（公告）日：2010-02-09